cepharanthine has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hattori, S; Kariya, R; Komizu, Y; Matsuda, K; Okada, S; Ueoka, R | 1 |
| Baba, M; Okamoto, M; Ono, M | 1 |
2 other study(ies) available for cepharanthine and HIV Coinfection
| Article | Year |
|---|---|
Cepharanthine inhibited HIV-1 cell-cell transmission and cell-free infection via modification of cell membrane fluidity.
Topics: Benzylisoquinolines; Cells, Cultured; HEK293 Cells; HIV Fusion Inhibitors; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Jurkat Cells; Lymphocytes; Membrane Fluidity; Stephania; Virus Internalization | 2014 |
Potent inhibition of HIV type 1 replication by an antiinflammatory alkaloid, cepharanthine, in chronically infected monocytic cells.
Topics: Alkaloids; Anti-HIV Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Cell Line; Dose-Response Relationship, Drug; HeLa Cells; HIV Infections; HIV Long Terminal Repeat; HIV-1; Humans; Monocytes; NF-kappa B; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transfection; Tumor Necrosis Factor-alpha; Virus Replication | 1998 |